GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » ZimVie Inc (NAS:ZIMV) » Definitions » Debt-to-EBITDA

ZIMV (ZimVie) Debt-to-EBITDA : 5.93 (As of Sep. 2024)


View and export this data going back to 2022. Start your Free Trial

What is ZimVie Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

ZimVie's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2024 was $4.4 Mil. ZimVie's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2024 was $229.8 Mil. ZimVie's annualized EBITDA for the quarter that ended in Sep. 2024 was $39.5 Mil. ZimVie's annualized Debt-to-EBITDA for the quarter that ended in Sep. 2024 was 5.93.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for ZimVie's Debt-to-EBITDA or its related term are showing as below:

ZIMV' s Debt-to-EBITDA Range Over the Past 10 Years
Min: -1.03   Med: 0.8   Max: 7.37
Current: 7.37

During the past 6 years, the highest Debt-to-EBITDA Ratio of ZimVie was 7.37. The lowest was -1.03. And the median was 0.80.

ZIMV's Debt-to-EBITDA is ranked worse than
89.1% of 431 companies
in the Medical Devices & Instruments industry
Industry Median: 1.54 vs ZIMV: 7.37

ZimVie Debt-to-EBITDA Historical Data

The historical data trend for ZimVie's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ZimVie Debt-to-EBITDA Chart

ZimVie Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-EBITDA
Get a 7-Day Free Trial 0.80 -1.03 0.38 6.89 5.73

ZimVie Quarterly Data
Dec18 Dec19 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.18 13.41 24.25 9.20 5.93

Competitive Comparison of ZimVie's Debt-to-EBITDA

For the Medical Devices subindustry, ZimVie's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ZimVie's Debt-to-EBITDA Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, ZimVie's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where ZimVie's Debt-to-EBITDA falls into.



ZimVie Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

ZimVie's Debt-to-EBITDA for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(4.053 + 517.877) / 91.073
=5.73

ZimVie's annualized Debt-to-EBITDA for the quarter that ended in Sep. 2024 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(4.438 + 229.758) / 39.484
=5.93

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Sep. 2024) EBITDA data.


ZimVie  (NAS:ZIMV) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


ZimVie Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of ZimVie's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


ZimVie Business Description

Traded in Other Exchanges
N/A
Address
10225 Westmoor Drive, Westminster, CO, USA, 80021
ZimVie Inc is focused on the dental and spine markets and their respective growth drivers such as implants, surgical tools, bone graft substitutes, spinal fusion implants, non-fusion alternatives, and digital care management solutions. Business is organized into two operating segments the spine products segment and the dental products segment.
Executives
Camber Capital Management Lp 10 percent owner 101 HUNTINGTON AVENUE, SUITE 2101, BOSTON MA 02199
Sally Crawford director C/O HOLOGIC, INC., BEDFORD MA 01730
Vafa Jamali director, officer: See Remarks C/O ZIMVIE INC., 10225 WESTMOOR DRIVE, WESTMINSTER CO 80021
Richard Heppenstall officer: See Remarks C/O ZIMVIE INC., 10225 WESTMOOR DRIVE, WESTMINSTER CO 80021
Zimmer Biomet Holdings, Inc. 10 percent owner 345 EAST MAIN STREET, WARSAW IN 46580
Richard Kuntz director MEDTRONIC, INC., 710 MEDTRONIC PWKY MS LC 310, MINNEAPOLIS MN 55432
Vinit K Asar director 10910 DOMAIN DRIVE, SUITE 300, AUSTIN TX 78758
Karen Matusinec director C/O ZIMVIE INC., 10225 WESTMOOR DRIVE, WESTMINSTER CO 80021
David P King director PRIVIA HEALTH GROUP, INC., 950 N. GLEBE RD., SUITE 700, ARLINGTON VA 22203
Rebecca Ann Whitney officer: See Remarks 10225 WESTMOOR DRIVE, WESTMINSTER CO 80021
David John Harmon officer: See Remarks 10225 WESTMOOR DRIVE, WESTMINSTER CO 80021
Indraneel Kanaglekar officer: See Remarks C/O ZIMVIE INC., 10225 WESTMOOR DRIVE, WESTMINSTER CO 80021
Heather Kidwell officer: See Remarks C/O ZIMVIE INC., 10225 WESTMOOR DRIVE, WESTMINSTER CO 80021
Sandra Schneider officer: Chief Accounting Officer C/O ZIMVIE INC., 10225 WESTMOOR DRIVE, WESTMINSTER CO 80021

ZimVie Headlines

From GuruFocus

Eversept Partners, LP Expands Stake in ZimVie Inc

By GuruFocus News 11-15-2024

ZimVie Inc (ZIMV) Shares Up 3.34% on Sep 12

By GuruFocus Research 09-12-2024

Q1 2024 ZimVie Inc Earnings Call Transcript

By GuruFocus Research 05-09-2024

Q1 2023 ZimVie Inc Earnings Call Transcript

By GuruFocus Research 02-09-2024

Q3 2024 ZimVie Inc Earnings Call Transcript

By GuruFocus News 10-31-2024

Q2 2023 ZimVie Inc Earnings Call Transcript

By GuruFocus Research 02-09-2024

Q4 2023 ZimVie Inc Earnings Call Transcript

By GuruFocus Research 02-29-2024